Beurswaarde geschiedenis voor Asensus Surgical, Inc.
| Datum | Beurswaarde |
|---|---|
| 29 sep. 2023 | 64.683.900,00 US$ |
| 28 sep. 2023 | 66.600.460,00 US$ |
| 27 sep. 2023 | 68.181.622,00 US$ |
| 26 sep. 2023 | 61.353.877,00 US$ |
| 25 sep. 2023 | 62.719.425,00 US$ |
| 22 sep. 2023 | 64.923.470,00 US$ |
| 21 sep. 2023 | 65.929.664,00 US$ |
| 20 sep. 2023 | 68.876.375,00 US$ |
| 19 sep. 2023 | 67.079.600,00 US$ |
| 18 sep. 2023 | 67.989.966,00 US$ |
| 15 sep. 2023 | 69.475.300,00 US$ |
| 14 sep. 2023 | 77.117.583,00 US$ |
| 13 sep. 2023 | 71.871.000,00 US$ |
| 12 sep. 2023 | 72.230.355,00 US$ |
| 11 sep. 2023 | 75.728.077,00 US$ |
Beurswaarde in Healthcare bedrijven
| Bedrijfsnaam | Beurswaarde | |
|---|---|---|
 |
Abbott Laboratories ABT |
168.416.997.483,00 US$ |
 |
AbbVie Inc. ABBV |
263.389.020.000,00 US$ |
 |
American Shared Hospital Services AMS |
15.649.920,00 US$ |
 |
Amplifon S.p.A. AMP.MI |
6.278.577.285,00 US$ |
 |
AstraZeneca PLC AZN |
209.932.000.000,00 US$ |
 |
Atossa Therapeutics, Inc. ATOS |
93.257.839,00 US$ |
 |
Baxter International Inc. BAX |
19.096.440.000,00 US$ |
 |
Bayer Aktiengesellschaft BAYN.DE |
44.739.406.800,00 US$ |
 |
BeiGene, Ltd. BGNE |
18.820.273.676,00 US$ |
 |
BioCryst Pharmaceuticals, Inc. BCRX |
1.338.955.440,00 US$ |
 |
Biogen Inc. BIIB |
37.189.347.000,00 US$ |
 |
BIOLASE, Inc. BIOL |
1.013.700,00 US$ |
 |
Bionano Genomics, Inc. BNGO |
9.543.894,00 US$ |
 |
BioNTech SE BNTX |
26.183.615.165,00 US$ |
 |
Bristol-Myers Squibb Company BMY |
121.477.720.000,00 US$ |
 |
Cegedim SA CGM.PA |
249.128.267,00 US$ |
 |
Clover Health Investments, Corp. CLOV |
517.496.852,00 US$ |
 |
CRISPR Therapeutics AG CRSP |
3.645.235.819,00 US$ |
 |
EssilorLuxottica Société anonyme EL.PA |
73.061.994.580,00 US$ |
 |
Eurofins Scientific SE ERF.PA |
10.298.750.000,00 US$ |
 |
Exicure, Inc. XCUR |
6.071.323,68 US$ |
 |
Fagron NV FAGR.BR |
1.174.016.250,00 US$ |
 |
Galapagos NV GLPG.AS |
2.126.141.347,00 US$ |
 |
Galapagos NV GLPG |
2.258.167.339,00 US$ |
 |
Genfit S.A. GNFT |
162.433.770,00 US$ |
 |
Genmab A/S GMAB |
23.010.283.648,00 US$ |
 |
GoodRx Holdings, Inc. GDRX |
2.320.804.230,00 US$ |
 |
Healthcare Triangle, Inc. HCTI |
16.110.123,00 US$ |
 |
iBio, Inc. IBIO |
3.716.357,50 US$ |
 |
Inovio Pharmaceuticals, Inc. INO |
102.833.641,00 US$ |
 |
Intrasense SA ALINS.PA |
12.868.052,00 US$ |
 |
Jaguar Health, Inc. JAGX |
4.584.193,64 US$ |
 |
Johnson & Johnson JNJ |
404.752.832.181,00 US$ |
 |
Koninklijke Philips N.V. PHIA.AS |
17.455.567.990,00 US$ |
 |
Media Lab S.p.A. MLLAB.PA |
2.986.200,00 US$ |
 |
Medtronic plc MDT |
104.257.980.000,00 US$ |
 |
Merck & Co., Inc. MRK |
261.390.050.000,00 US$ |
 |
Moderna, Inc. MRNA |
39.353.490.000,00 US$ |
 |
Nektar Therapeutics NKTR |
112.959.113,00 US$ |
 |
NextGen Healthcare, Inc. NXGN |
1.576.239.588,00 US$ |
 |
Novacyt S.A. ALNOV.PA |
50.850.898,00 US$ |
 |
Novan, Inc. NOVN |
1.462.495,22 US$ |
 |
Novavax, Inc. NVAX |
646.980.880,00 US$ |
 |
Novo Nordisk A/S NVO |
204.178.488.000,00 US$ |
 |
Nutex Health, Inc. NUTX |
132.954.041,00 US$ |
 |
Ocugen, Inc. OCGN |
95.324.599,00 US$ |
 |
OpGen, Inc. OPGN |
2.502.278,20 US$ |
 |
Orchard Therapeutics plc ORTX |
145.752.366,00 US$ |
 |
Organon & Co. OGN |
4.432.719.760,00 US$ |
 |
Pear Therapeutics, Inc. PEAR |
4.050.252,52 US$ |
 |
Pfizer Inc. PFE |
187.277.820.000,00 US$ |
 |
Pharming Group N.V. PHARM.AS |
783.882.105,00 US$ |
 |
Privia Health Group, Inc. PRVA |
2.671.708.773,00 US$ |
 |
Roche Holding AG RO.SW |
215.519.999.999,00 US$ |
 |
Sanofi SAN.PA |
126.910.888.000,00 US$ |
 |
Signify Health, Inc. SGFY |
8.933.386.237,00 US$ |
 |
Teladoc Health, Inc. TDOC |
3.051.945.805,00 US$ |
 |
Thermo Fisher Scientific Inc. TMO |
195.381.620.000,00 US$ |
 |
Tilray Brands, Inc. TLRY |
1.504.130.147,00 US$ |
 |
Tonix Pharmaceuticals Holding Corp. TNXP |
5.769.967,32 US$ |
 |
Vaxart, Inc. VXRT |
105.254.055,00 US$ |
 |
Vertex Pharmaceuticals Incorporated VRTX |
89.612.598.000,00 US$ |
 |
Zomedica Corp. ZOM |
163.749.589,00 US$ |
